Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

Peptimmune and Peptide Therapeutics form asthma, autoimmune disease collaboration

March 30, 1998

Inspire, NeoGenesis form respiratory drugs collaboration

March 27, 1998

Byk Gulden claims PDE IV inhibitors for respiratory disorders, dermatoses

March 27, 1998

Novel compounds for allergic/inflammatory disorders discovered at Astra

March 27, 1998

TOBI now available for CF patients with P. aeruginosa

March 26, 1998

HSR-609: a potent and insurmountable H1 antagonist in vitro

March 26, 1998

Hoechst discovers inhibitors of various inflammatory mediators

March 25, 1998

CytoMed and UCB join forces to develop antiinflammatory therapeutics

March 25, 1998

PathoGenesis seeks Canadian approval for TOBI in CF

March 25, 1998

New antiasthmatic agents claimed by Byk Gulden

March 25, 1998

Popular Stories

Today's news in brief
BioWorld
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...